Clara, CA, October 13, 2020, / Press Release/ -
business and science behind nanotech biosensors to detect viruses and bacteria
attract deep tech investors and researchers.
hosted an online event on the new business and science behind nanotech
biosensors. Deep tech investors see the unprecedented market opportunity and
scientific researchers appreciate the Nanotechnology behind the biosensor.
biosensor is a technology that detects viruses and bacteria with high
sensitivity and selectivity using nano-sized noble metals like Gold, Silver,
Palladium, and Platinum.
nano biosensor has a biological recognition unit and transducer that interact
with antibodies and enzymes and change the bio-elemental properties into
surface plasma resonance signal, says Dr. Sivakumar, Chief Technology Officer
of Ariviya Inc.
CEO of Ariviya, Inc, said, the Infectious disease diagnostics market size is 23
Billion USD, with a 7.5% CAGR by 2027. The key growth drivers are increased
infectious diseases' incidences globally and growing awareness of early
detection. But the impact of COVID-19 in our lifestyle is hyper-accelerating
these growth drivers.
COVID-19 era, the rising awareness about self-monitoring & diagnosis and
the rapid advancement in the detection technology fuels the global
home/self-diagnostics market. People perform these tests at non-healthcare
places like home and workplaces to quickly identify medical conditions,
cost-effectively, and repeatedly. Read that "repeatedly" as a vast
and continuous market, like FMCG.
being a "deep technology startup" founded on real science and
technology innovations with strong R&D in Nanotechnology and Biotechnology,
attracts investors to invest in its nanotech biosensor research and product
development to meet these new huge needs.
is a Nano biotech Startup from the heart of Silicon Valley at Santa Clara,
California, with an R&PD center in India, invents scientific, scalable,
marketable solutions for real-world problems in human wellness & animal
welfare. At Ariviya, we apply Lean methodology and Deep Technologies from
Nanotechnology, Biotechnology, Polymer Technology in research and product
development, and commercialization. Ariviya's technology pipelines are deep
science-based and balanced to de-risk investments. They consist of Nano
Biosensors Technology, Natural Antimicrobial Polymer Technology, Wound Care
& Burn Management Technology, and Natural Udder Care Technology.
more information about the company, please visit www.ariviya.com.
Patrick Henry Dr,
Clara, CA, 95054, United States